Large-scale testing (Phase 3)Active Not RecruitingNCT04812925
What this trial is testing
Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia
Who this might be right for
Primary Immune Thrombocytopenia
argenx 173